Lipum Investor Relations Material
Latest events
Q4 2023
Lipum
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Lipum
Access all reports
Lipum AB, a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases. The company focuses on developing small molecule inhibitors of G protein-coupled receptors that regulate inflammation through modulation of intracellular trafficking pathways and other mechanisms. The company is based in Umeå, Sweden.
Latest articles
Companies That Had Their IPO in 2019: Bull Market and Tech Dominance
Discussing the stock and IPO market in 2019, and the factors that led to the overall bullish performance of stocks during the year.
3 May 2024
Microsoft's Journey to Becoming the World's Most Valuable Company
Explore Microsoft's rise from a garage startup to the world's most valuable company, highlighting Bill Gates' role in shaping the digital revolution.
3 May 2024
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
Ticker symbol
Country
🇸🇪 Sweden